Cough Suppressants Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Type (Dextromethorphan, Codeine, Noscapine, Others); Form (Tablet/Pill, Syrup, Inhalers, Others); End User (Hospitals, Clinics, Others) and Geography
Report Code: TIPRE00017804 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Cough is a prevalent symptom of various upper and lower respiratory tract infections. It is a reflex response to mechanical, chemical, or inflammatory irritation of the tracheobronchial tree, which is conveyed by sensory neurons in the airways reflexly through neurons present in the brainstem. Antitussives, also known as cough suppressants, are widely used to relieve the symptoms of cough. The cough suppressant works by reducing the activity of cough reflex and suppresses the urge to cough. Dextromethorphan and Codeine are the two most common cough suppressant drugs widely used in the treatment of cough.
MARKET DYNAMICS
The cough suppressants market has shown a significant evolution over the forecast period. The rise of the cough suppressants market is majorly driven by the vulnerable indoor and outdoor allergens and improvement in treatment. High cases of cough hypersensitivity syndrome associated with Gastroesophageal Reflux Disease (GERD) also act as a positive indicator for the rise in market growth. Moreover, according to the data published by the National Center for Biotechnology Information in 2014, cough is the most common reason for visits to primary care physicians globally, accounting for around 8% of all consultations. According to the same source, the annual prevalence of cough in the general population is approximately 10-33% globally. However, some stringent regulations against cough suppressant drugs are expected to hinder the global cough suppressants market growth during the forecast period. For instance, in January 2020, the FDA introduced a regulation that inhibits the use of codeine-based cough suppressant drugs in children less than 18 years of age.
MARKET SCOPE
The "Cough Suppressants Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry's pharmaceuticals, with a specific focus on the global market trend analysis. This report provides an outline of the cough suppressants market with detailed market segmentation by drug type, form, and end-user. The cough suppressants market is estimated to witness high growth during the forecast period. It focuses on the vital statistics on the leading players' market status in the cough suppressants market and offers key opportunities and trends.
MARKET SEGMENTATION
The market is categorized based on the drug type, form, and end user. Based on the drug type, the market is segmented as dextromethorphan, codeine, noscapine, and others. Based on the form, the segmentation of the market is into tablet/pill, syrup, inhalers, and others. Based on end user, segmentation of the market is into hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report states a comprehensive outline of the industry, consisting of both qualitative and quantitative information. It gives a sketch and forecast of the cough suppressants market based on various segments. The report also comprises market size and forecast estimates from the year 2020 to2028with respect to five primary regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East, and Africa (MEA), and South & Central America (SCAM). The cough suppressants market by each region is then sub-segmented into respective countries and segments. It provides the analysis and forecast of 18 countries worldwide and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the cough suppressants market from both the demand and supply sides. Moreover, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also comprises a precise PEST analysis for all five regions, namely, North America, APAC, Europe, MEA, and South & Central America, after assessing political, social, economic, and technological factors affecting the cough suppressants market in these regions.
The report contains critical developments in the cough suppressants market as inorganic and organic growth strategies. Multiple companies are pivoting on organic growth strategies like product approvals, product launches, and others, such as events and patents. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Many such activities have paved the path for elaborating the business and customer base of market players. The market players from the cough suppressants market are estimated to have profitable growth opportunities in the coming years, with a higher demand for cough suppressants in the global market. Mentioned below is the list of a few companies engaged in the cough suppressants market.
The report also provides key players' profiles in the cough suppressants market, along with their SWOT analysis and market strategies. Moreover, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
The Insight Partner's dedicated research and the analytical team consists of experienced professionals with advanced statistical expertise and provides various customization options in the current study.
Cough is a prevalent symptom of various upper and lower respiratory tract infections. It is a reflex response to mechanical, chemical, or inflammatory irritation of the tracheobronchial tree, which is conveyed by sensory neurons in the airways reflexly through neurons present in the brainstem. Antitussives, also known as cough suppressants, are widely used to relieve the symptoms of cough. The cough suppressant works by reducing the activity of cough reflex and suppresses the urge to cough. Dextromethorphan and Codeine are the two most common cough suppressant drugs widely used in the treatment of cough.
MARKET DYNAMICS
The cough suppressants market has shown a significant evolution over the forecast period. The rise of the cough suppressants market is majorly driven by the vulnerable indoor and outdoor allergens and improvement in treatment. High cases of cough hypersensitivity syndrome associated with Gastroesophageal Reflux Disease (GERD) also act as a positive indicator for the rise in market growth. Moreover, according to the data published by the National Center for Biotechnology Information in 2014, cough is the most common reason for visits to primary care physicians globally, accounting for around 8% of all consultations. According to the same source, the annual prevalence of cough in the general population is approximately 10-33% globally. However, some stringent regulations against cough suppressant drugs are expected to hinder the global cough suppressants market growth during the forecast period. For instance, in January 2020, the FDA introduced a regulation that inhibits the use of codeine-based cough suppressant drugs in children less than 18 years of age.
MARKET SCOPE
The "Cough Suppressants Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry's pharmaceuticals, with a specific focus on the global market trend analysis. This report provides an outline of the cough suppressants market with detailed market segmentation by drug type, form, and end-user. The cough suppressants market is estimated to witness high growth during the forecast period. It focuses on the vital statistics on the leading players' market status in the cough suppressants market and offers key opportunities and trends.
MARKET SEGMENTATION
The market is categorized based on the drug type, form, and end user. Based on the drug type, the market is segmented as dextromethorphan, codeine, noscapine, and others. Based on the form, the segmentation of the market is into tablet/pill, syrup, inhalers, and others. Based on end user, segmentation of the market is into hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report states a comprehensive outline of the industry, consisting of both qualitative and quantitative information. It gives a sketch and forecast of the cough suppressants market based on various segments. The report also comprises market size and forecast estimates from the year 2020 to2028with respect to five primary regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East, and Africa (MEA), and South & Central America (SCAM). The cough suppressants market by each region is then sub-segmented into respective countries and segments. It provides the analysis and forecast of 18 countries worldwide and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the cough suppressants market from both the demand and supply sides. Moreover, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also comprises a precise PEST analysis for all five regions, namely, North America, APAC, Europe, MEA, and South & Central America, after assessing political, social, economic, and technological factors affecting the cough suppressants market in these regions.
The report contains critical developments in the cough suppressants market as inorganic and organic growth strategies. Multiple companies are pivoting on organic growth strategies like product approvals, product launches, and others, such as events and patents. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Many such activities have paved the path for elaborating the business and customer base of market players. The market players from the cough suppressants market are estimated to have profitable growth opportunities in the coming years, with a higher demand for cough suppressants in the global market. Mentioned below is the list of a few companies engaged in the cough suppressants market.
The report also provides key players' profiles in the cough suppressants market, along with their SWOT analysis and market strategies. Moreover, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
- Pfizer Inc.
- Atley Pharmaceuticals, Inc.
- Novartis International AG
- Merck & Co., Inc.
- F. Hoffmann-La Roche Ltd
- AstraZeneca
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- 3M
- Teva Pharmaceuticals Industries Ltd
The Insight Partner's dedicated research and the analytical team consists of experienced professionals with advanced statistical expertise and provides various customization options in the current study.
1. Pfizer Inc.
2. Atley Pharmaceuticals, Inc.
3. Novartis International AG
4. Merck & Co., Inc.
5. F. Hoffmann-La Roche Ltd
6. AstraZeneca
7. Sanofi
8. Sun Pharmaceutical Industries Ltd.
9. 3M
10. Teva Pharmaceuticals Industries Ltd
2. Atley Pharmaceuticals, Inc.
3. Novartis International AG
4. Merck & Co., Inc.
5. F. Hoffmann-La Roche Ltd
6. AstraZeneca
7. Sanofi
8. Sun Pharmaceutical Industries Ltd.
9. 3M
10. Teva Pharmaceuticals Industries Ltd
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000 $2700
$4550 $4095$6550 $5568$8550 $6840Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount
